Stanford University
Showing 15,671-15,680 of 35,025 Results
-
Pallavi Kompella
Lead Research Scientist, Animal Pharmacology, Innovative Medicines Accelerator (IMA)
BioPh.D. Pharmaceutical Sciences, The University of Texas at Austin, Texas
(American Foundation for Pharmaceutical Education Doctoral Fellow)
Fulbright Postdoctoral Scholar, Biomedical Research Institute of Malaga, Spain -
Praneeta R. Konduri
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Konduri is a Postdoctoral scholar at the Department of Neurology and Neurological Sciences. With a background in biomedical engineering, she conducted her PhD research as part of a European consortium that developed computational stroke models, while also analyzing post-treatment brain tissue damage from multicenter clinical trials to assess prognosis. After completing her PhD, she continued as a Postdoctoral Researcher within the European consortium GEMINI, that aimed to implement digital twins for personalized stroke treatment. At the Stanford Stroke Center, she now focusses on developing AI tools for stroke diagnosis, treatment evaluation, prognostication, and personalized treatment development.
-
Silvana Maria Konermann
Assistant Professor of Biochemistry
BioSilvana is an Assistant Professor of Biochemistry at Stanford and Executive Director and Core Investigator at Arc Institute. Her research laboratory aims to understand the molecular pathways that drive the development of Alzheimer’s disease using next-generation functional genomics, with the long-term goal of developing rationally targeted therapeutics for neurodegenerative disorders. She received her Ph.D. in Neuroscience from MIT. Silvana’s pioneering work on tools to directly perturb the transcriptomic landscape of the cell using CRISPR has been recognized by her faculty appointment as a Chan Zuckerberg Biohub Investigator and Hanna Gray Fellow of the Howard Hughes Medical Institute.
-
Christina Kong
Professor of Pathology
Current Research and Scholarly InterestsImproving the accuracy of cytologic diagnosis through the use of ancillary techniques on specimens obtained by fine needle aspiration biopsy.
Identifying potential indicators of prognosis in head and neck squamous cell carcinomas.
Evaluating the utility of immunohistochemical stains in refining the diagnosis of squamous dysplasia of the cervix, vulva, and head and neck.
